IGC Pharma, Inc. - Neraca (Quarterly)

IGC Pharma, Inc.
US ˙ NYSEAM ˙ US45408X3089

Talaan ng Balanse (Quarterly)

Neraca IGC Pharma, Inc. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 1 1 15 13 14 12 10 8 7 5 3 2 3 1 1 2 2 0 0 0
Change (%) -15.90 1,402.89 -8.45 8.11 -17.07 -12.40 -23.01 -17.76 -25.34 -35.37 -46.09 75.62 -54.46 -13.06 52.25 -15.24 -69.60 -13.83 12.10
Assets Current 14 11 24 22 22 19 15 13 11 9 6 5 6 4 4 4 4 3 3 2
Change (%) -16.56 105.91 -5.64 -2.19 -11.37 -21.45 -15.78 -12.01 -16.47 -30.87 -21.47 20.46 -41.43 3.40 18.95 -3.56 -28.21 -5.08 -25.66
Assets 26 24 36 34 34 31 27 24 22 20 17 16 17 11 10 11 10 9 9 8
Change (%) -8.29 48.44 -3.97 -1.77 -7.53 -14.24 -9.94 -9.14 -8.60 -14.41 -8.76 5.31 -31.79 -12.05 6.99 -2.12 -12.45 -3.65 -9.19
Liabilities 3 3 3 3 3 2 3 2 2 2 2 2 2 2 3 3 3 3 2 2
Change (%) -2.07 13.86 -11.65 -4.69 -29.73 62.27 -27.74 -14.68 -3.36 29.32 9.00 -2.55 -8.39 17.00 5.15 10.24 -5.78 -14.26 -22.84
Equity 24 21 33 32 31 29 24 22 20 18 15 13 14 9 7 8 7 6 6 6
Change (%) -9.01 52.77 -3.25 -1.52 -5.70 -18.94 -7.75 -8.60 -9.07 -18.59 -11.46 6.79 -35.79 -19.13 7.64 -6.38 -15.16 1.13 -3.98
Liabilities And Stock Equity 26 24 36 34 34 31 27 24 22 20 17 16 17 11 10 11 10 9 9 8
Change (%) -8.29 48.44 -3.97 -1.77 -7.53 -14.24 -9.94 -9.14 -8.60 -14.41 -8.76 5.31 -31.79 -12.05 6.99 -2.12 -12.45 -3.65 -9.19

Source: Capital IQ

Other Listings
DE:IGS1 € 0.36
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista